Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4568298
Max Phase: Preclinical
Molecular Formula: C36H45NO3
Molecular Weight: 539.76
Molecule Type: Unknown
Associated Items:
ID: ALA4568298
Max Phase: Preclinical
Molecular Formula: C36H45NO3
Molecular Weight: 539.76
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@@H]1CC(=O)C[C@H]2c3cc(OCc4ccc(C(C)(C)C)cc4)c(OCc4ccc(C(C)(C)C)cc4)cc3CCN12
Standard InChI: InChI=1S/C36H45NO3/c1-24-18-30(38)20-32-31-21-34(40-23-26-10-14-29(15-11-26)36(5,6)7)33(19-27(31)16-17-37(24)32)39-22-25-8-12-28(13-9-25)35(2,3)4/h8-15,19,21,24,32H,16-18,20,22-23H2,1-7H3/t24-,32+/m1/s1
Standard InChI Key: JFYVQWDLBGHLKQ-QNLPTKCRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 539.76 | Molecular Weight (Monoisotopic): 539.3399 | AlogP: 8.09 | #Rotatable Bonds: 6 |
Polar Surface Area: 38.77 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 6.98 | CX LogP: 8.64 | CX LogD: 8.50 |
Aromatic Rings: 3 | Heavy Atoms: 40 | QED Weighted: 0.32 | Np Likeness Score: 0.11 |
1. Zheng H, Dong Y, Li L, Sun B, Liu L, Yuan H, Lou H.. (2016) Novel Benzo[a]quinolizidine Analogs Induce Cancer Cell Death through Paraptosis and Apoptosis., 59 (10): [PMID:27077446] [10.1021/acs.jmedchem.6b00484] |
Source(1):